RICHMOND, Calif. - Michimich -- DeepThink Health, Inc., a technology innovator in advanced analytics and artificial intelligence for precision medicine, announced today that Intermountain Healthcare is strengthening its cross-organizational Molecular Tumor Board with the adoption of DeepThink's Precision Tumor Board Solution.
The Precision Tumor Board Solution from DeepThink delivers a streamlined workflow and collaborative learning system that supports multi-organizational and national tumor boards and enables multi-disciplinary clinicians to participate synchronously or asynchronously, in-person or remotely, and via web or mobile applications. With DeepThink's smart search and cohort analytics, clinicians can compare a specific patient to similar patients and analyze their outcome and prognosis within the institution or across broader evidence sharing networks. The solution enables evidence-based decision making for molecular testing, therapy selection, and clinical trial matching. It provides quality and compliance reporting, as well as outcome analytics to monitor consistency in care and value-based performance.
More on Michimich.com
"We are excited to partner with DeepThink as we continue to advance our efforts in precision medicine." said Lincoln D. Nadauld, MD, Vice President of Precision Health for Intermountain Healthcare. "DeepThink's solutions enhance our ability to scale precision medicine practice by simplifying access to complex health data, liberating key insights from real-world data, and supporting tumor board management with real-time access for clinicians."
"We're pleased to be expanding our working relationship with Intermountain Healthcare, one of the world's leading precision medicine programs," said David C. Dvorak, Chairman and Chief Executive Officer of DeepThink Health. "Because cancer is driven by genetic change, sophisticated solutions are needed at the point of care in order to incorporate clinical and molecular insights into patient treatment decisions. Through this multi-year arrangement, Intermountain is deploying the DeepThink technology that is specifically designed to address this need. We look forward to working closely with Intermountain as we strive to bring the full promise of precision medicine to the treatment of patients."
For more information visit www.deepthinkhealth.com
The Precision Tumor Board Solution from DeepThink delivers a streamlined workflow and collaborative learning system that supports multi-organizational and national tumor boards and enables multi-disciplinary clinicians to participate synchronously or asynchronously, in-person or remotely, and via web or mobile applications. With DeepThink's smart search and cohort analytics, clinicians can compare a specific patient to similar patients and analyze their outcome and prognosis within the institution or across broader evidence sharing networks. The solution enables evidence-based decision making for molecular testing, therapy selection, and clinical trial matching. It provides quality and compliance reporting, as well as outcome analytics to monitor consistency in care and value-based performance.
More on Michimich.com
- Maccabi USA Men's Basketball Announces New Head Coach For 21st Maccabiah
- Michigan: Meridian Road bridge repairs over I-96 underway in Ingham County
- Michigan: Attorney General Nessel Urges Senate to Pass Legislation to Ensure Relief for all Federal Student Loan Borrowers Impacted by COVID-19 Pandemic
- Michigan: Attorney General Nessel Announces Appointment of Oceana County Public Administrator
- Michigan: MDOT virtual meeting to give update on 2020-21 M-28 project in Munising
"We are excited to partner with DeepThink as we continue to advance our efforts in precision medicine." said Lincoln D. Nadauld, MD, Vice President of Precision Health for Intermountain Healthcare. "DeepThink's solutions enhance our ability to scale precision medicine practice by simplifying access to complex health data, liberating key insights from real-world data, and supporting tumor board management with real-time access for clinicians."
"We're pleased to be expanding our working relationship with Intermountain Healthcare, one of the world's leading precision medicine programs," said David C. Dvorak, Chairman and Chief Executive Officer of DeepThink Health. "Because cancer is driven by genetic change, sophisticated solutions are needed at the point of care in order to incorporate clinical and molecular insights into patient treatment decisions. Through this multi-year arrangement, Intermountain is deploying the DeepThink technology that is specifically designed to address this need. We look forward to working closely with Intermountain as we strive to bring the full promise of precision medicine to the treatment of patients."
For more information visit www.deepthinkhealth.com
Source: DeepThink Health
0 Comments
Latest on Michimich.com
- Andrew Carnegie Global Capital Has Announced an Equity Investment in a Brantstone Properties Development Project – London, Slated 2023
- What if Bon Jovi's Drummer Had Been an Indian Temple Musician From 800AD?
- Michigan: MDHHS Director Robert Gordon Issues Statement on Order Requiring Testing of Farm and Food Processing Employees
- New Memoir By U.S. Marine: Releasing on Amazon September 06 2020
- Building Your Success System. Unique New eBook
- Onlive Server Announced Europe based Germany VPS Server Hosting Services with KVM Hypervisor Cloud Panel
- Platinum Educational Group Announces Sponsorship of the National Registry of Emergency Medical Techn
- ICON Jewel's Famed Hollywood Jeweler Talks Diamonds, Covid And These Uncertain Times
- Governor's Fitness Awards Move to Virtual Celebration
- Why We Need More Black Executives in Hip Hop? by Eric B
- Michigan: Eastbound I-94 closed at M-60 in Jackson starting Thursday for bridge demolition
- Michigan: Eastbound I-94 ramp to southbound US-127 closed in Jackson starting on Saturday
- Governor Whitmer Extends Declaration of Emergency As Michigan Continues to Fight COVID-19
- Michigan: AG Nessel Announces Settlement Eliminating Telecom Carrier Responsible for Illegal Robocalls
- Michigan: Governor Whitmer Makes Appointment to Ogemaw County Probate Court
- Michigan: MPSC to hold public hearing on Enbridge's request for siting authority to replace, relocate Line 5 in Straits of Mackinac
- Additional food assistance for 350,000 Michigan families in response to COVID-19 extended through August
- Michigan: M-89 resurfacing in Richland starts Monday
- Michigan: AG Nessel Joins Bipartisan Coalition Urging Federal Government Action to Increase Access and Affordability for COVID-19 Drug
- Herman Miller Upholds Win in Ongoing Fight to Protect Iconic Designs from Trademark Infringement